These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23619471)

  • 1. Secreted osteoclastogenic factor of activated T cells (SOFAT), a novel osteoclast activator, in chronic periodontitis.
    Jarry CR; Duarte PM; Freitas FF; de Macedo CG; Clemente-Napimoga JT; Saba-Chujfi E; Passador-Santos F; de Araújo VC; Napimoga MH
    Hum Immunol; 2013 Jul; 74(7):861-6. PubMed ID: 23619471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOFAT as a Putative Marker of Osteoclasts in Bone Lesions.
    Cândido-Soares LE; Martinez EF; de Araújo VC; Araújo NS; Freitas NS; Napimoga MH
    Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):448-453. PubMed ID: 29489507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of SOFAT by T- and B-lineage cells may contribute to bone loss.
    Jarry CR; Martinez EF; Peruzzo DC; Carregaro V; Sacramento LA; Araújo VC; Weitzmann MN; Napimoga MH
    Mol Med Rep; 2016 May; 13(5):4252-8. PubMed ID: 27035849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of the biological effect of SOFAT on osteoblasts.
    Napimoga MH; Demasi AP; Jarry CR; Ortega MC; de Araújo VC; Martinez EF
    Int Immunopharmacol; 2015 Jun; 26(2):378-83. PubMed ID: 25916677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner.
    Rifas L; Weitzmann MN
    Arthritis Rheum; 2009 Nov; 60(11):3324-35. PubMed ID: 19877052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted Osteoclastogenic Factor of Activated T Cells (SOFAT) Is Associated With Rheumatoid Arthritis and Joint Pain: Initial Evidences of a New Pathway.
    Napimoga MH; Dantas Formiga WD; Abdalla HB; Trindade-da-Silva CA; Venturin CM; Martinez EF; Rossaneis AC; Verri WA; Clemente-Napimoga JT
    Front Immunol; 2020; 11():1442. PubMed ID: 32849501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminothiazoles inhibit osteoclastogenesis and PGE
    Kats A; Gerasimcik N; Näreoja T; Nederberg J; Grenlöv S; Lagnöhed E; Desai S; Andersson G; Yucel-Lindberg T
    J Cell Mol Med; 2019 Feb; 23(2):1152-1163. PubMed ID: 30506812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of RANKL-induced osteoclasts and memory T lymphocytes by Porphyromonas gingivalis is serotype dependant.
    Vernal R; Díaz-Zúñiga J; Melgar-Rodríguez S; Pujol M; Diaz-Guerra E; Silva A; Sanz M; Garcia-Sanz JA
    J Clin Periodontol; 2014 May; 41(5):451-9. PubMed ID: 24476556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY
    Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble RANKL Cleaved from Activated Lymphocytes by TNF-α-Converting Enzyme Contributes to Osteoclastogenesis in Periodontitis.
    Kanzaki H; Makihira S; Suzuki M; Ishii T; Movila A; Hirschfeld J; Mawardi H; Lin X; Han X; Taubman MA; Kawai T
    J Immunol; 2016 Nov; 197(10):3871-3883. PubMed ID: 27815441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W; Dou H; Liu X; Sun L; Hou Y
    Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of secreted osteoclastogenic factor of activated T cells in bone remodeling.
    Zhang R; Peng S; Zhu G
    Jpn Dent Sci Rev; 2022 Nov; 58():227-232. PubMed ID: 35898473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPAR-gamma agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis.
    Hassumi MY; Silva-Filho VJ; Campos-Júnior JC; Vieira SM; Cunha FQ; Alves PM; Alves JB; Kawai T; Gonçalves RB; Napimoga MH
    Int Immunopharmacol; 2009 Sep; 9(10):1150-8. PubMed ID: 19508902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.
    Wisitrasameewong W; Kajiya M; Movila A; Rittling S; Ishii T; Suzuki M; Matsuda S; Mazda Y; Torruella MR; Azuma MM; Egashira K; Freire MO; Sasaki H; Wang CY; Han X; Taubman MA; Kawai T
    J Dent Res; 2017 Jun; 96(6):685-693. PubMed ID: 28199142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis.
    Kim KW; Kim HR; Kim BM; Cho ML; Lee SH
    Am J Pathol; 2015 Nov; 185(11):3011-24. PubMed ID: 26362732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
    Asai K; Funaba M; Murakami M
    Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of osteoclast-like cells from peripheral blood of periodontitis patients occurs without supplementation of macrophage colony-stimulating factor.
    Tjoa ST; de Vries TJ; Schoenmaker T; Kelder A; Loos BG; Everts V
    J Clin Periodontol; 2008 Jul; 35(7):568-75. PubMed ID: 18435789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T and B Cells in Periodontal Disease: New Functions in A Complex Scenario.
    Figueredo CM; Lira-Junior R; Love RM
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31416146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells.
    Ko SY
    Arch Oral Biol; 2012 Dec; 57(12):1623-32. PubMed ID: 22795564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.
    Valverde P; Kawai T; Taubman MA
    J Bone Miner Res; 2004 Jan; 19(1):155-64. PubMed ID: 14753747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.